BayBio:IMPACT 2005 documents the effect that the Northern California life science industry has on patients' lives everyday:

• More than 240 products on the market are from Northern California saving lives everyday;
• Patients in the U.S. alone have received over 2 billion doses annually from Northern California;
• 200 products are in Phase II/III development in Northern California addressing major unmet medical needs;
• More than a third of all domestic public biotech companies are located in Northern California, representing a collective value of $150 billion and investing close to $4 billion annually in research;
• More companies and employees are focused on life science in Northern California than in any other national or international region.

Download the report here:

Introduction and Chapter One: Executive Summary (1.3 MB)

Chapter Two: Cancer (598 KB)

Chapter Three: Heart, Blood and Veins (638 KB)

Chapter Four: Infectious Diseases (620 KB)

Chapter Five: Central Nervous System (594 KB)

Chapter Six: Metabolic Disorders (649 KB)

Chapter Seven: Urinary Tract (533 KB)

Chapter Eight: Liver Conditions (532 KB)

Chapter Nine: Men's and Women's Issues (462 KB)

Chapter Ten: Respiratory and Pulmonary (600 KB)

Chapter Eleven: Immune System (525 KB)

Chapter Twelve: Digestive Disorders (791 KB)

Chapter Thirteen: Bones (802 KB)

Chapter Fourteen: Eye Conditions (526 KB)

Chapter Fifteen: Neonatal (508 KB)

Chapter Sixteen: Dermatology (541 KB)

Chapter Seventeen: Surgery and Wounds (545 KB)

Chapter Eighteen: Testing and Supplies (576 KB)

Appendix I: Life Science Products in Clinical Trials, Appendix II: About the Contributors, Index I and Index II: Companies and Keywords (1.4 MB)

Download the Full Report (6.1 MB)

Media coverage of BayBio:IMPACT 2005:

NPR’s “BioTech Nation” features launch of BayBio:IMPACT (listen by streaming audio)

Biotech Group Urges Steps… (S.J. Mercury News, carried by Bradenton [FL] Herald, St. Paul [MN] Pioneer Press)

Bay Area’s Claim on Biotech Enters Phase II Trials (S.F. Bus. Times)

Life Sciences Short of Workers, Threatened by Rivals (East Bay Bus. Jrnl)

$4 Billion Spent Each Year on Region’s Biotech Research (S.J. Bus. Jrnl)

For further information, contact Travis Blaschek-Miller at BayBio.